Other Event Calendars
- Stanford Events
- Stanford Global Studies
- All APARC Events
- Asia Health Policy Program (AHPP)
- China Program
- Japan Program
- Korea Program
- Southeast Asia Program
- Freeman Spogli Institute for International Studies
- Ho Center for Buddhist Studies at Stanford
- Stanford Program on Regions of Innovation and Entrepreneurship
The Globalization of Clinical Investigations: BRIC (Brazil, Russia, India, China) and Beyond
Ernst Berndt- Louis E. Seley Professor in Applied Economics,MIT Sloan School of Management
PLEASE NOTE UPDATED NEW LOCATION
Joint event with Stanford Health Policy Program
No RSVP required.
In this colloquium hosted jointly by the Asia Health Policy Program and the Center for Health Policy (CHP/PCOR), Professor Ernst Berndt will discuss the globalization of clinical trials, particularly into India, China, and other emerging economies. In research using data from "ClinicalTrials.gov" with co-authors Iain M. Cockburn, Howard L. Golub, and Fabio Thiers, Berndt finds that the globalization of clinical trials is extensive, and varies substantially across countries and therapeutic areas. Clinical research conducted in emerging regions predominantly involves later stage (Phase III) industry-sponsored biopharmaceutical and vaccine trials, especially in oncology, cardiovascular and infectious diseases. Comparatively low per capita participation rates in countries with large populations like China and India suggest extensive opportunities for growth.
Ernst R. Berndt is the Louis E. Seley Professor in Applied Economics at the MIT Sloan School of Management. The focus of his recent research has been on the changing dynamics of the health care industries, such as how medical innovations have affected the costs of treating selected diseases over time, incentives to induce R&D into third world diseases, and the impact of direct-to-consumer marketing of prescription pharmaceuticals. More generally, Berndt's research deals with assessing the sources of productivity growth and how productivity is measured.
Professor Berndt is also co-director of the Biomedical Enterprise Program (a joint program of MIT Sloan and the Harvard-MIT Division of Health Sciences and Technology) and serves as Director of the National Bureau of Economic Research Program on Technological Progress and Productivity Measurement.
Wednesday, January 27, 2010 | 1:30 pm — 3:00 pm